20/20 Capital Management »

SPDR S&P Biotech shares owned by 20/20 Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by 20/20 Capital Management from 13F filings

Historical chart of 20/20 Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by 20/20 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by 20/20 Capital Management

Quarter filed Position value Share count Share price at filing
2021-06-30 $537k 4.0k 135.30
2021-03-31 $465k 3.4k 135.77
2020-12-31 $521k 3.2k 163.32

More positions owned by 20/20 Capital Management

Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Specialized Funds Div App Etf (VIG)
Proshares Tr S&p 500 Dv Arist (NOBL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Blackrock Science & Technolo SHS (BST)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
J P Morgan Exchange-traded F Ultra Shrt Inc (JPST)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vaneck Vectors Etf Tr Pharmaceutical (PPH)
J P Morgan Exchange-traded F Intl Bd Opp Etf (JPIB)
Wisdomtree Tr Emer Mkt High Fd (DEM)
Apple (AAPL)

View all positions for 20/20 Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Susquehanna International
Citadel Advisors
Bank of America Corporation
Citigroup
Jpmorgan Chase & Co
Morgan Stanley
Millennium Management
venBio Select Advisor
Bnp Paribas Arbitrage, Snc
UBS Group
Healthcare Of Ontario Pension Plan Trust Fund
Soleus Capital Management
Capital Fund Management
Wells Fargo & Company

View all funds holding SPDR S&P Biotech